Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Sarobe

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Identification and characterization of a T-helper peptide from carcinoembryonic antigenMarta Ruiz, Hiroya Kobayashi, Juan José Lasarte, et al.
International Journal of Cancer|January 5, 2002
Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigenEduardo Huarte, Pablo Sarobe, Juan José Lasarte, et al.
Journal of Virology|September 27, 2003
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responsesPablo Sarobe, Juan José Lasarte, Aintzane Zabaleta, et al.
Cardiovascular Research|November 21, 2008
A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive ratsNerea Hermida, Begoña López, Arantxa González, et al.
Oncoimmunology|April 9, 2016
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccinationDiana Llopiz, Fernando Aranda, Nancy Díaz-Valdés, et al.
International Immunology|May 17, 2003
Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responsesAscensión López-Díaz de Cerio, Juan José Lasarte, Noelia Casares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccineTakahiro Okazaki, C David Pendleton, Pablo Sarobe, et al.
Oncoimmunology|March 3, 2025
MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinomaDiana Llopiz, Leyre Silva, Marta Ruiz, et al.
Journal of Hepatology|January 15, 2014
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infectionEsther Larrea, Itziar Echeverria, Jose-I Riezu-Boj, et al.
Vaccine|April 28, 2005
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirusLaura Arribillaga, Pablo Sarobe, Ainhoa Arina, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Identification and characterization of a T-helper peptide from carcinoembryonic antigenMarta Ruiz, Hiroya Kobayashi, Juan José Lasarte, et al.
International Journal of Cancer|January 5, 2002
Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigenEduardo Huarte, Pablo Sarobe, Juan José Lasarte, et al.
Journal of Virology|September 27, 2003
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responsesPablo Sarobe, Juan José Lasarte, Aintzane Zabaleta, et al.
Cardiovascular Research|November 21, 2008
A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive ratsNerea Hermida, Begoña López, Arantxa González, et al.
Oncoimmunology|April 9, 2016
Vaccine-induced but not tumor-derived Interleukin-10 dictates the efficacy of Interleukin-10 blockade in therapeutic vaccinationDiana Llopiz, Fernando Aranda, Nancy Díaz-Valdés, et al.
International Immunology|May 17, 2003
Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responsesAscensión López-Díaz de Cerio, Juan José Lasarte, Noelia Casares, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Epitope enhancement of a CD4 HIV epitope toward the development of the next generation HIV vaccineTakahiro Okazaki, C David Pendleton, Pablo Sarobe, et al.
Oncoimmunology|March 3, 2025
MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinomaDiana Llopiz, Leyre Silva, Marta Ruiz, et al.
Journal of Hepatology|January 15, 2014
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infectionEsther Larrea, Itziar Echeverria, Jose-I Riezu-Boj, et al.
Vaccine|April 28, 2005
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirusLaura Arribillaga, Pablo Sarobe, Ainhoa Arina, et al.
Pageof 9